Noninvasive Tests for Hepatic Fibrosis Form

Chat with GenHealth to automate any policy or prior auth task.


ultrasound transient elastography (eg, FibroScan)

Notes: Please refer to the specific pharmacy coverage policies for Hemgenix and RoctavianTM for additional information regarding their use.

Indications

(94216) Has the patient been diagnosed with chronic HCV evidenced by either quantitative tests (HCV RNA viral load) and/or qualitative tests (HCV antibody positive serum serology)? 
(94217) Has the patient been diagnosed with chronic liver disease as evidenced by sustained elevation of liver function tests (LTFs) for greater than 6 months? 
(94218) Is ultrasound transient elastography required prior to the use of Hemgenix (etranacogene dezaparvovec-drib) for treatment of Hemophilia B? 
(94219) Is ultrasound transient elastography required prior to the use of RoctavianTM (valoctocogene roxaparvovec-rvox) for the treatment of Hemophilia A? 
(94220) Has a liver biopsy not been performed on the patient within the previous 6 months? 

YesNoN/A
YesNoN/A
YesNoN/A

Sign up to see the rest of the questions

Unlock the remaining questions and the full coverage workflow.

Sign up for free
Effective Date

09/28/2023

Last Reviewed

NA

Original Document

  Reference



Noninvasive Tests for Hepatic Fibrosis

Medical Coverage Policy

Effective Date: 09/28/2023
Revision Date: 09/28/2023
Review Date: 02/02/2023
Policy Number: HUM-0529-015
Page: 1 of 18
Change Summary: Updated Coverage Determination

Humana's documents are updated regularly online. When printed, the version of this document becomes uncontrolled. Do not rely on printed copies for the most up-to-date version. Refer to Medical and Pharmacy Coverage Policies to verify that this is the current version before utilizing.

Disclaimer

Medical Alternatives

Description

Book a walkthrough

Walk through this policy with us

Review how this policy can be converted into cited criteria, prior authorization checks, and operational automation.